Ginkgo Bioworks Holdings Inc. DNA / LAYER Stock

Overview Charts & Stats for the Selected Time Period

This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.

Settings

Asset DNA / LAYER

Latest Price 100.90

Price Change % Calculating...

Price Change X Calculating...

Up Days Calculating...

Down Days Calculating...

Avg Up Day % Calculating...

Avg Down Day % Calculating...

Median Up Day % Calculating...

Median Down Day % Calculating...

Volatility % 10.07%

Win Rate % 57.5%

CAGR % +4,476.33%

Best Day % +62.13%

Worst Day % -28.08%

Max Drawdown % -76.44%

Period High 120.67

Period Low 2.26

From High % -15.6%

From Low % +4,396.9%

Sharpe Ratio 0.15

Days >Avg % 40.2%

Total Volume 907,346,041

Volume: 2026-02-17

Aggregate Volume: 241 Days

Price Chart Percentage Gains

The price chart compares the percentage returns for each asset in the given time period. Each starts out at 0% at the x axis left most position.

Price Overlay ChartPercentage Gains

The overlay price chart displays the price movements of each asset over the selected period, using individual y-axes for each. This allows for an easy comparison of assets with different magnitudes, making it great for identifying correlations.

Volume Chart Daily Volume

This volume chart shows the daily volume for each asset.

Learn More

This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.

What is Ginkgo Bioworks Holdings Inc.?

This company operates at the forefront of synthetic biology, a rapidly expanding field that integrates biology and engineering. It functions as a platform organism company, offering its proprietary technology to design and manufacture biological products. Essentially, it provides custom cell programming services, enabling other businesses to develop novel solutions across various sectors. Its core offering involves using advanced software, automation, and data analytics to engineer microorganisms for specific purposes. This includes developing new cell-based therapeutics, sustainable agricultural products, and bio-based chemicals. The company's platform aims to accelerate the discovery and development timelines for these biological innovations, positioning it as a key enabler for the growing bioeconomy. Its business model is largely service-based, partnering with pharmaceutical, agricultural, and industrial biotechnology companies to bring their bio-engineered products to market.

🤖 AI Analysis

Model:

Ask me anything about the data on this page. I can help explain metrics, identify patterns, or answer specific questions.

Data sources

Trade hundreds of crypto perpetual futures